Characterization of Epstein-Barr virus recombinants with deletions of the BamHI C promoter
- PMID: 8610445
- DOI: 10.1006/viro.1996.0148
Characterization of Epstein-Barr virus recombinants with deletions of the BamHI C promoter
Abstract
Epstein-Barr virus (EBV) recombinants with the BamHI C promoter (Cp) deleted were compared with wild-type Cp recombinants derived in parallel for their ability to initiate and maintain latent infection and growth transformation in primary human B lymphocytes. Cp-deleted recombinants infected, transformed, and immortalized B lymphocytes in vitro as efficiently as wild-type Cp recombinant EBV. Lymphoblastoid cell lines (LCLs) infected with the Cp-deleted recombinant were indistinguishable from wild-type recombinant-infected LCLs in latent gene expression, growth rate, morphology, and surface phenotype. Deletion of Cp did not affect episomal maintenance or spontaneous entry of the virus into lytic cycle. The effect of steroid hormones on latent and lytic gene expression on Cp-deleted recombinants was analyzed and shown to be independent of the glucocorticoid response element located 5' to Cp. The BamHI W promoter, Wp, is used to transcribe EBNA genes in Cp-deleted EBV-infected cells. Wp is sufficient for growth transformation and maintenance of the lymphoblastoid phenotype of EBV-infected lymphocytes in vitro.
Similar articles
-
Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.Virology. 1993 Apr;193(2):774-85. doi: 10.1006/viro.1993.1186. Virology. 1993. PMID: 8384755
-
Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.J Med Virol. 2003 Jul;70(3):410-9. doi: 10.1002/jmv.10411. J Med Virol. 2003. PMID: 12767005
-
The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.J Virol. 1992 Dec;66(12):7461-8. doi: 10.1128/JVI.66.12.7461-7468.1992. J Virol. 1992. PMID: 1331531 Free PMC article.
-
Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.Autoimmunity. 2008 May;41(4):298-328. doi: 10.1080/08916930802024772. Autoimmunity. 2008. PMID: 18432410 Review.
-
Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus.Semin Cancer Biol. 2008 Dec;18(6):409-15. doi: 10.1016/j.semcancer.2008.09.001. Epub 2008 Sep 30. Semin Cancer Biol. 2008. PMID: 18938248 Review.
Cited by
-
B-cell lines immortalized with an Epstein-Barr virus mutant lacking the Cp EBNA2 enhancer are biased toward utilization of the oriP-proximal EBNA gene promoter Wp1.J Virol. 1997 Dec;71(12):9134-42. doi: 10.1128/JVI.71.12.9134-9142.1997. J Virol. 1997. PMID: 9371570 Free PMC article.
-
Role of Epstein-Barr Virus C Promoter Deletion in Diffuse Large B Cell Lymphoma.Cancers (Basel). 2021 Feb 1;13(3):561. doi: 10.3390/cancers13030561. Cancers (Basel). 2021. PMID: 33535665 Free PMC article.
-
EBNA2 amino acids 3 to 30 are required for induction of LMP-1 and immortalization maintenance.J Virol. 2004 Apr;78(8):3919-29. doi: 10.1128/jvi.78.8.3919-3929.2004. J Virol. 2004. PMID: 15047808 Free PMC article.
-
Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter.J Virol. 2006 Nov;80(22):11200-8. doi: 10.1128/JVI.00897-06. Epub 2006 Sep 6. J Virol. 2006. PMID: 16956945 Free PMC article.
-
RNA polymerase II stalling promotes nucleosome occlusion and pTEFb recruitment to drive immortalization by Epstein-Barr virus.PLoS Pathog. 2011 Oct;7(10):e1002334. doi: 10.1371/journal.ppat.1002334. Epub 2011 Oct 27. PLoS Pathog. 2011. PMID: 22046134 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
